{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:47:18Z","timestamp":1785854838240,"version":"3.56.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>The purpose of this review is to describe the intersection between pediatric hypertension and advancing stages of cardiovascular, kidney metabolic syndrome in children and adolescents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic syndrome is highly prevalent in the pediatric population. The onset of CKM in childhood is influenced by the presence of antenatal risk factors such as maternal hypertensive disorders of pregnancy. Advancing stages of CKM in children and adolescents are strongly influenced by food insecurity and social determinants of health that impact the risk for childhood obesity. Activation of the renin-angiotensin-aldosterone system is a key mediator in the relationship between antenatal risk, early life course exposure and hypertension in children and adolescents. Effective strategies for slowing the rate of advancement of CKM staging in children and adolescents require attention to early course factors that influence the development of hypertension and obesity. Likewise, management strategies and therapeutic interventions that address these factors are critical to mitigating CKM stage advancement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Although hypertension is a component of the CKM framework, the presence of hypertension in children and adolescents drives higher CKM staging. Together, hypertension and higher CKM staging are associated with increased atherosclerotic cardiovascular disease risk. Social factors, including access to healthy foods and attention to early life course nutrition are critical strategies to improving CKM and hypertension related outcomes in children and adolescents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11906-026-01375-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:58:31Z","timestamp":1782230311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Jessica","family":"O\u2019Keeffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kingshill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Tompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3204-4142","authenticated-orcid":false,"given":"Andrew M.","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-1586","authenticated-orcid":false,"given":"Carissa M.","family":"Baker-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"20","key":"1375_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: A presidential advisory from the american heart association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"20","key":"1375_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American heart association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"6 Pt 2","key":"1375_CR3","doi-asserted-by":"publisher","first-page":"101843","DOI":"10.1016\/j.jacadv.2025.101843","volume":"4","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wu X, Long T, et al. Prevalence and mortality association of different stages of cardiovascular-kidney-metabolic syndrome. JACC Adv. 2025;4(6 Pt 2):101843.","journal-title":"JACC Adv"},{"issue":"1","key":"1375_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1159\/000546618","volume":"15","author":"L Lei","year":"2025","unstructured":"Lei L, Li J, Ding W, et al. Associations of cardiovascular-kidney-metabolic syndrome with premature mortality and life expectancies in US adults: A cohort study. Cardiorenal Med. 2025;15(1):484\u201395.","journal-title":"Cardiorenal Med"},{"issue":"10","key":"1375_CR5","doi-asserted-by":"publisher","first-page":"e040269","DOI":"10.1161\/JAHA.124.040269","volume":"14","author":"CM Baker-Smith","year":"2025","unstructured":"Baker-Smith CM, Gauen AM, Petito LC, Khan SS, Allen NB. Prevalence of cardiovascular-kidney-metabolic stages in US adolescents and relationship to social determinants of health. J Am Heart Assoc. 2025;14(10):e040269.","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"1375_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"8","key":"1375_CR7","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/dom.13303","volume":"20","author":"SV Arnold","year":"2018","unstructured":"Arnold SV, Kosiborod M, Wang J, Fenici P, Gannedahl G, LoCasale RJ. Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry. Diabetes Obes Metab. 2018;20(8):2000\u20133.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl1","key":"1375_CR8","first-page":"A4142830","volume":"150","author":"A South","year":"2024","unstructured":"South A, Baker-Smith C, Campbell J, et al. Abstract 4142830: High prevalence of cardiovascular-kidney-metabolic syndrome and lack of sex disparities in youth referred for hypertension disorders: A SUPERHERO Analysis. Circulation. 2024;150(Suppl1):A4142830\u20134142830.","journal-title":"Circulation"},{"issue":"5","key":"1375_CR9","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1161\/HYP.0000000000000227","volume":"80","author":"BT Alexander","year":"2023","unstructured":"Alexander BT, South AM, August P, et al. Appraising the preclinical evidence of the role of the renin-angiotensin-aldosterone system in antenatal programming of maternal and offspring cardiovascular health across the life course: Moving the field forward: A scientific statement from the American heart association. Hypertension. 2023;80(5):e75\u201389.","journal-title":"Hypertension"},{"key":"1375_CR10","doi-asserted-by":"crossref","unstructured":"Tain YL, Lin YJ, Hsu CN. Breastfeeding and future cardiovascular, kidney, and metabolic health-a narrative review. Nutrients 2025;17(6):1\u201323.","DOI":"10.3390\/nu17060995"},{"issue":"12","key":"1375_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11906-022-01227-z","volume":"24","author":"AM South","year":"2022","unstructured":"South AM, Allen NB. Antenatal programming of hypertension: Paradigms, paradoxes, and how we move forward. Curr Hypertens Rep. 2022;24(12):655\u201367.","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"1375_CR12","doi-asserted-by":"publisher","first-page":"104153","DOI":"10.1016\/j.numecd.2025.104153","volume":"35","author":"H Zhen","year":"2025","unstructured":"Zhen H, Chen L, Hao X, et al. Maternal blood pressure during pregnancy and children\u2019s cardiometabolic function: A birth cohort study. Nutr Metab Cardiovasc Dis. 2025;35(11):104153.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"1375_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ekir.2024.02.1437","volume":"9","author":"S Tzvi-Behr","year":"2024","unstructured":"Tzvi-Behr S, Greenstein LB, Ben-Shalom E, Frishberg Y, Cohen SO. Associations between prematurity, birthweight, and adolescence blood pressure in a nationwide cohort. Kidney Int Rep. 2024;9(5):1228\u201335.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"1375_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/ajh\/hpaf129","volume":"38","author":"SF Mayo","year":"2025","unstructured":"Mayo SF, Schaich CL, South AM, Shaltout HA. Arterial stiffness in young adults with very low birth weight: Modified by gestational age. Am J Hypertens. 2025;38(12):1136\u201343.","journal-title":"Am J Hypertens"},{"issue":"2","key":"1375_CR15","first-page":"143","volume":"2","author":"J Zhou","year":"2012","unstructured":"Zhou J, Qin G. Adipocyte dysfunction and hypertension. Am J Cardiovasc Dis. 2012;2(2):143\u20139.","journal-title":"Am J Cardiovasc Dis"},{"key":"1375_CR16","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska E, Bojdo K, Frankenstein H et al. Endothelial dysfunction as the common pathway linking obesity, hypertension and atherosclerosis. Int J Mol Sci 2025;26(20):1\u201334.","DOI":"10.3390\/ijms262010096"},{"issue":"3","key":"1375_CR17","first-page":"197","volume":"32","author":"MT Sch\u00fctten","year":"2017","unstructured":"Sch\u00fctten MT, Houben AJ, de Leeuw PW, Stehouwer CD. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiol (Bethesda). 2017;32(3):197\u2013209.","journal-title":"Physiol (Bethesda)"},{"issue":"5","key":"1375_CR18","first-page":"712","volume":"36","author":"LJ DeLalio","year":"2020","unstructured":"DeLalio LJ, Sved AF, Stocker SD. Sympathetic nervous system contributions to hypertension: Updates and therapeutic relevance. Can J Cardiol. 2020;36(5):712\u201320.","journal-title":"Can J Cardiol"},{"issue":"1","key":"1375_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13679-025-00679-z","volume":"15","author":"K Iqbal","year":"2026","unstructured":"Iqbal K, Chatziangelousi E, Wolters M, et al. Reference curves for metabolic syndrome indicators in children and adolescents: A global systematic review. Curr Obes Rep. 2026;15(1):3.","journal-title":"Curr Obes Rep"},{"issue":"2","key":"1375_CR20","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-kidney-metabolic (CKM) syndrome: A state-of-the-art review. Curr Probl Cardiol. 2024;49(2):102344.","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"1375_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11906-012-0279-2","volume":"14","author":"A Whaley-Connell","year":"2012","unstructured":"Whaley-Connell A, Sowers JR. Oxidative stress in the cardiorenal metabolic syndrome. Curr Hypertens Rep. 2012;14(4):360\u20135.","journal-title":"Curr Hypertens Rep"},{"key":"1375_CR22","doi-asserted-by":"crossref","unstructured":"Tain YL, Hsu CN. The renin-angiotensin system and cardiovascular-kidney-metabolic syndrome: Focus on early-life programming. Int J Mol Sci 2024;25(6) : 1-19.","DOI":"10.3390\/ijms25063298"},{"issue":"7","key":"1375_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1001\/jamapediatrics.2024.1543","volume":"178","author":"CH Robinson","year":"2024","unstructured":"Robinson CH, Hussain J, Jeyakumar N, et al. Long-term cardiovascular outcomes in children and adolescents with hypertension. JAMA Pediatr. 2024;178(7):688\u201398.","journal-title":"JAMA Pediatr"},{"issue":"12","key":"1375_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41371-025-01078-6","volume":"39","author":"L Ghazi","year":"2025","unstructured":"Ghazi L, Dubal M, Bertoni A, et al. Role of hypertension in the cardiovascular-kidney-metabolic syndrome among black adults: The Jackson Heart Study. J Hum Hypertens. 2025;39(12):822\u201330.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"1375_CR25","doi-asserted-by":"publisher","first-page":"e2557180","DOI":"10.1001\/jamanetworkopen.2025.57180","volume":"9","author":"X Guo","year":"2026","unstructured":"Guo X, Zhou S, Mu J, et al. Intensive blood pressure control and cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages: A post hoc analysis of the China rural hypertension control project. JAMA Netw Open. 2026;9(2):e2557180.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1375_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00467-024-06517-z","volume":"40","author":"AJ Kula","year":"2025","unstructured":"Kula AJ, Bartlett D. Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps. Pediatr Nephrol. 2025;40(3):651\u201360.","journal-title":"Pediatr Nephrol"},{"key":"1375_CR27","doi-asserted-by":"crossref","unstructured":"Rybi Szumi\u0144ska A, Wasilewska A, Kamianowska M. Protein biomarkers in chronic kidney disease in children-what do we know so far? J Clin Med 2023;12(12):1\u201321.","DOI":"10.3390\/jcm12123934"},{"issue":"1","key":"1375_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40200-026-01892-w","volume":"25","author":"J Xu","year":"2026","unstructured":"Xu J, Wang P, Yao B, Dong Y, Zhou S, Yan X. The urine albumin-to-creatinine ratio is associated with advanced cardiovascular-kidney-metabolic syndrome stages and mortality: an analysis of NHANES 1999\u20132018. J Diabetes Metab Disord. 2026;25(1):63.","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"1375_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652\u201360.","journal-title":"Kidney Int"},{"issue":"12","key":"1375_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang L, Tang K, Magee LA, et al. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. 2022;18(12):760\u201375.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1375_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/AOG.0000000000002433","volume":"131","author":"MM Rice","year":"2018","unstructured":"Rice MM, Landon MB, Varner MW, et al. Pregnancy-associated hypertension and offspring cardiometabolic health. Obstet Gynecol. 2018;131(2):313\u201321.","journal-title":"Obstet Gynecol"},{"issue":"8 Suppl B","key":"1375_CR32","first-page":"9","volume":"13","author":"SA Atlas","year":"2007","unstructured":"Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 Suppl B):9\u201320.","journal-title":"J Manag Care Pharm"},{"issue":"2b","key":"1375_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1079\/PHN2001145","volume":"4","author":"KM Godfrey","year":"2001","unstructured":"Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr. 2001;4(2b):611\u201324.","journal-title":"Public Health Nutr"},{"key":"1375_CR34","doi-asserted-by":"crossref","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017;140(3):1\u201372.","DOI":"10.1542\/peds.2017-3035"},{"key":"1375_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jpeds.2022.03.036","volume":"246","author":"Y Miyashita","year":"2022","unstructured":"Miyashita Y, Hanevold C, Faino A, et al. White coat hypertension persistence in children and adolescents: The pediatric nephrology research consortium study. J Pediatr. 2022;246:154\u2013e160151.","journal-title":"J Pediatr"},{"issue":"6 Pt 2","key":"1375_CR36","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.jacadv.2025.101795","volume":"4","author":"C Akubo","year":"2025","unstructured":"Akubo C, Washington IE, Song S, et al. DASH diet adherence and cardiovascular-kidney metabolic syndrome stages: National health and nutrition examination survey 2011\u20132020. JACC Adv. 2025;4(6 Pt 2):101795.","journal-title":"JACC Adv"},{"issue":"6 Pt 2","key":"1375_CR37","doi-asserted-by":"publisher","first-page":"101788","DOI":"10.1016\/j.jacadv.2025.101788","volume":"4","author":"I Shahid","year":"2025","unstructured":"Shahid I, Philip J, Avenatti E, et al. Lifestyle interventions in cardiovascular-kidney-metabolic syndrome JACC: Advances Expert Panel. JACC Adv. 2025;4(6 Pt 2):101788.","journal-title":"JACC Adv"},{"issue":"16","key":"1375_CR38","doi-asserted-by":"publisher","first-page":"e034996","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, et al. Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults. J Am Heart Assoc. 2024;13(16):e034996.","journal-title":"J Am Heart Assoc"},{"key":"1375_CR39","unstructured":"Palaniappan LP, Allen NB, Almarzooq ZI et al. 2026 Heart disease and stroke statistics: A report of US and global data from the american heart association. Circulation 2026:e275\u2013e906."},{"key":"1375_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.genhosppsych.2026.01.010","volume":"99","author":"Z Chen","year":"2026","unstructured":"Chen Z, Zhao W, Chen Z, et al. Adverse childhood experiences and cardiovascular disease risk in early-stage CKM: The mediating role of depressive symptoms. Gen Hosp Psychiatry. 2026;99:143\u201350.","journal-title":"Gen Hosp Psychiatry"},{"issue":"9","key":"1375_CR41","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2215\/CJN.0000000744","volume":"20","author":"J Rangaswami","year":"2025","unstructured":"Rangaswami J, Shlipak MG, Mathew RO, Ndumele CE. The cardiovascular-kidney-metabolic health framework: Implications for nephrology. Clin J Am Soc Nephrol. 2025;20(9):1299\u2013306.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1375_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/advances\/nmaa041","volume":"11","author":"CD Filippou","year":"2020","unstructured":"Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: A systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(5):1150\u201360.","journal-title":"Adv Nutr"},{"issue":"3","key":"1375_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00467-024-06531-1","volume":"40","author":"E Degraeuwe","year":"2025","unstructured":"Degraeuwe E, Gasthuys E, Snauwaert E, et al. Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management: a 10-year cohort study. Pediatr Nephrol. 2025;40(3):797\u2013809.","journal-title":"Pediatr Nephrol"},{"issue":"17","key":"1375_CR44","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"W\u00fchl E, Trivelli A, Picca S, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639\u201350.","journal-title":"N Engl J Med"},{"issue":"4","key":"1375_CR45","first-page":"e58019","volume":"16","author":"T Sinha","year":"2024","unstructured":"Sinha T, Khilji F, Laraib F, et al. The effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors on cardiovascular outcomes and all-cause mortality in patients with acute coronary syndrome: A systematic review and meta-analysis. Cureus. 2024;16(4):e58019.","journal-title":"Cureus"},{"issue":"34","key":"1375_CR46","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"1","key":"1375_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000533970","volume":"10","author":"I Losin","year":"2024","unstructured":"Losin I, Hagai KC, Pereg D. The treatment of coronary artery disease in patients with chronic kidney disease: Gaps, challenges, and solutions. kidney dis (Basel). 2024;10(1):12\u201322.","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"1375_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/ndt\/gfae180","volume":"40","author":"O Gross","year":"2025","unstructured":"Gross O, Boeckhaus J, Weber LT, et al. Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport. Nephrol Dial Transpl. 2025;40(4):679\u201387.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"1375_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kint.2025.10.003","volume":"109","author":"F Schaefer","year":"2026","unstructured":"Schaefer F. SGLT-2 inhibition in pediatric CKD: advances, challenges, and opportunities. Kidney Int. 2026;109(1):2\u20135.","journal-title":"Kidney Int"},{"key":"1375_CR50","doi-asserted-by":"crossref","unstructured":"Oni L, Trachtman H, Smoyer WE, Seide S, Hammad S, McKenzie J, WCN26-9365 Pharmacokinetics, safety and efficacy of empagliflozin in paediatric patients with chronic kidney disease: Design of the empa-kidney kids randomised controlled trial. Kidney International Reports. 2026;11(4, Supplement):105789.","DOI":"10.1016\/j.ekir.2026.105789"},{"issue":"1","key":"1375_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13063-024-08021-z","volume":"25","author":"F Schaefer","year":"2024","unstructured":"Schaefer F, Montini G, Kang HG, et al. Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies. Trials. 2024;25(1):203.","journal-title":"Trials"},{"issue":"23","key":"1375_CR52","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219\u201329.","journal-title":"N Engl J Med"},{"issue":"5","key":"1375_CR53","first-page":"Cd015328","volume":"5","author":"F Spiga","year":"2024","unstructured":"Spiga F, Davies AL, Tomlinson E, et al. Interventions to prevent obesity in children aged 5 to 11 years old. Cochrane Database Syst Rev. 2024;5(5):Cd015328.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1375_CR54","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1186\/s12889-025-25254-y","volume":"25","author":"J Men","year":"2025","unstructured":"Men J, Yu Z, An W, et al. Effects of exercise on cardiorespiratory fitness in children and adolescents with overweight and obesity: a systematic review and meta-analysis of 72 randomized controlled trials. BMC Public Health. 2025;25(1):3899.","journal-title":"BMC Public Health"},{"issue":"4","key":"1375_CR55","doi-asserted-by":"publisher","first-page":"690","DOI":"10.52082\/jssm.2024.690","volume":"23","author":"Y Song","year":"2024","unstructured":"Song Y, Lan H. The effects of high-intensity interval training on cardiometabolic health in children and adolescents: A systematic review and meta-analysis. J Sports Sci Med. 2024;23(4):690\u2013706.","journal-title":"J Sports Sci Med"},{"issue":"12","key":"1375_CR56","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2337\/dca25-0027","volume":"48","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang Y, Chen J, et al. Transition of BMI status from childhood to adulthood and cardiovascular-kidney-metabolic syndrome in midlife: A 36-Year Cohort Study. Diabetes Care. 2025;48(12):2045\u201353.","journal-title":"Diabetes Care"},{"key":"1375_CR57","unstructured":"National Institute on Minority Health and Health Disparities . NIMHD Research Framework. Retrieved from. 2025:1. https:\/\/wwwnimhd.nih.gov\/researchFramework. Accessed 1 Jul 2024."},{"key":"1375_CR58","doi-asserted-by":"crossref","unstructured":"Ikomi C, Baker-Smith CM. Where a child lives matters: neighborhood deprivation and pediatric obesity. Curr Opin Pediatr. 2023;36(1):3\u20139.","DOI":"10.1097\/MOP.0000000000001317"},{"key":"1375_CR59","doi-asserted-by":"crossref","unstructured":"Kelly AS, Bensignor MO, Hsia DS et al. Phentermine\/topiramate for the treatment of adolescent obesity. NEJM Evid 2022;1(6):1\u201318.","DOI":"10.1056\/EVIDoa2200014"},{"issue":"23","key":"1375_CR60","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","volume":"293","author":"JP Chanoine","year":"2005","unstructured":"Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873\u201383.","journal-title":"JAMA"},{"issue":"22","key":"1375_CR61","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","volume":"382","author":"AS Kelly","year":"2020","unstructured":"Kelly AS, Auerbach P, Barrientos-Perez M, et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med. 2020;382(22):2117\u201328.","journal-title":"N Engl J Med"},{"key":"1375_CR62","doi-asserted-by":"crossref","unstructured":"Salama M, Hassan D, Kumar S. Updates on anti-obesity medications in children and adolescents. Child (Basel) 2025;12(10):1\u201319.","DOI":"10.3390\/children12101390"},{"issue":"24","key":"1375_CR63","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","volume":"387","author":"D Weghuber","year":"2022","unstructured":"Weghuber D, Barrett T, Barrientos-P\u00e9rez M, et al. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022;387(24):2245\u201357.","journal-title":"N Engl J Med"},{"issue":"3","key":"1375_CR64","doi-asserted-by":"publisher","first-page":"101641","DOI":"10.1016\/j.diabet.2025.101641","volume":"51","author":"J Chen","year":"2025","unstructured":"Chen J, Cooper ME, Coughlan MT. Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists. Diabetes Metab. 2025;51(3):101641.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1375_CR65","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/cvr\/cvac112","volume":"119","author":"S Madsbad","year":"2023","unstructured":"Madsbad S, Holst JJ. Cardiovascular effects of incretins: focus on glucagon-like peptide-1 receptor agonists. Cardiovasc Res. 2023;119(4):886\u2013904.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"1375_CR66","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamapediatrics.2025.3243","volume":"179","author":"P Kotecha","year":"2025","unstructured":"Kotecha P, Huang W, Yeh YY, et al. Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes: A systematic review and meta-analysis. JAMA Pediatr. 2025;179(12):1308\u201317.","journal-title":"JAMA Pediatr"},{"key":"1375_CR67","doi-asserted-by":"crossref","unstructured":"Peterson AL, Ashraf AP, Bachman J et al. Screening, diagnosis, and management of pediatric hypertriglyceridemia: A scientific statement from the american heart association. Arterioscler Thromb Vasc Biol. 2026;46(4):931\u2013946.","DOI":"10.1161\/ATV.0000000000000195"},{"issue":"3","key":"1375_CR68","first-page":"481","volume":"43","author":"EH Ulrich","year":"2025","unstructured":"Ulrich EH, Kernizan D, Chanchlani R, Baker-Smith C. Cardio-kidney metabolic health in pediatrics and primordial prevention. Cardiol Clin. 2025;43(3):481\u201390.","journal-title":"Cardiol Clin"},{"issue":"5","key":"1375_CR69","doi-asserted-by":"publisher","first-page":"e2610702","DOI":"10.1001\/jamanetworkopen.2026.10702","volume":"9","author":"O Ekwunife","year":"2026","unstructured":"Ekwunife O, Wang X, Fraser RA, et al. Social risk factors and disparities in advanced cardiovascular-kidney-metabolic syndrome. JAMA Netw Open. 2026;9(5):e2610702.","journal-title":"JAMA Netw Open"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-026-01375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-026-01375-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-026-01375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:03:09Z","timestamp":1782234189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-026-01375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1007\/s11906-026-01375-6","relation":{},"ISSN":["1534-3111"],"issn-type":[{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"28"}}